Details

Autor(en) / Beteiligte

• Simonen, Piia
• Öörni, Katariina
• Sinisalo, Juha
• Strandberg, Timo E.
• Wester, Ingmar
• Gylling, Helena

Titel

High cholesterol absorption: A risk factor of atherosclerotic cardiovascular diseases?

Ist Teil von

• Atherosclerosis, 2023-07, Vol.376, p.53-62

Ort / Verlag

Ireland: Elsevier B.V

Erscheinungsjahr

2023

Quelle

MEDLINE

Beschreibungen/Notizen

• Lowering elevated low-density lipoprotein cholesterol (LDL-C) concentrations reduces the risk of atherosclerotic cardiovascular diseases (ASCVDs). However, increasing evidence suggests that cholesterol metabolism may also be involved in the risk reduction of ASCVD events. In this review, we discuss if the different profiles of cholesterol metabolism, with a focus on high cholesterol absorption, are atherogenic, and what could be the possible mechanisms. The potential associations of cholesterol metabolism and the risk of ASCVDs are evaluated from genetic, metabolic, and population-based studies and lipid-lowering interventions. According to these studies, loss-of-function genetic variations in the small intestinal sterol transporters ABCG5 and ABCG8 result in high cholesterol absorption associated with low cholesterol synthesis, low cholesterol elimination from the body, and a high risk of ASCVDs. In contrast, loss-of-function genetic variations in another intestinal sterol transporter, NPC1L1 result in low cholesterol absorption associated with high cholesterol synthesis, elevated cholesterol elimination from the body, and low risk of ASCVDs. Statin monotherapy is not sufficient to reduce the ASCVD risk in cases of high cholesterol absorption, and these individuals need combination therapy of statin with cholesterol absorption inhibition. High cholesterol absorption, i.e., >60%, is estimated to occur in approximately one third of a population, so taking it into consideration is important to optimise lipid-lowering therapy to prevent atherosclerosis and reduce the risk of ASCVD events. [Display omitted] •Elevated low-density lipoproteins cause atherosclerotic cardiovascular diseases (ASCVDs).•However, increased evidence suggests that high cholesterol absorption causes ASCVDs.•Genetic, metabolic, population, and lipid-lowering studies confirmed this concept.•High cholesterol absorption is relatively frequent in humans.•The treatment: a combination of cholesterol synthesis and absorption inhibition.